Bexarotene: A Case Study of Medicare Part D's Specialty Drug Shortcomings

被引：1
|
作者：
Puri, Pranav [1 ]
Rajkumar, S. Vincent [2 ]
Shah, Nilay D. [3 ]
Pittelkow, Mark R. [4 ]
Mangold, Aaron R. [4 ]
机构：
[1] Mayo Clin, Alix Sch Med, Scottsdale, AZ USA
[2] Mayo Clin, Dept Hematol, Rochester, MN USA
[3] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA
[4] Mayo Clin, Dept Dermatol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA
来源：
MAYO CLINIC PROCEEDINGS | 2021年 / 96卷 / 10期
关键词：
PRICES;
D O I：
10.1016/j.mayocp.2021.06.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2519 / 2522
页数：4
相关论文
共 50 条
  • [41] Medicare's Part D Drug Benefit At 10 Years: Firmly Established But Still Evolving
    Hoadley, John F.
    Cubanski, Juliette
    Neuman, Patricia
    HEALTH AFFAIRS, 2015, 34 (10) : 1682 - 1687
  • [42] Specialty biologic drug coverage under medicare Part D: The experience of vulnerable beneficiaries with rheumatoid arthritis (RA) and multiple sclerosis (MS)
    Polinski, J. M.
    Mohr, P. E.
    Johnson, L.
    VALUE IN HEALTH, 2008, 11 (03) : A35 - A35
  • [43] Numeracy and Medicare Part D: The Importance of Choice and Literacy for Numbers in Optimizing Decision Making for Medicare's Prescription Drug Program
    Wood, Stacey
    Hanoch, Yaniv
    Barnes, Andrew
    Liu, Pi-Ju
    Cummings, Janet
    Bhattacharya, Chandrima
    Rice, Thomas
    PSYCHOLOGY AND AGING, 2011, 26 (02) : 295 - 307
  • [44] The effect of transitioning to medicare part D drug coverage in seniors dually eligible for medicare and medicaid
    Shrank, W. H.
    Patrick, A.
    Pedan, A.
    Polinski, J.
    Varasteh, T.
    Levin, R.
    Liu, N.
    Schneeweiss, S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 412 - 413
  • [45] The effect of transitioning to Medicare part D drug coverage in seniors dually eligible for medicare and medicaid
    Shrank, William H.
    Patrick, Amanda R.
    Pedan, Alex
    Polinski, Jennifer M.
    Varesteh, Laleh
    Levin, Raisa
    Liu, Nan
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S207 - S207
  • [46] The Effect of Transitioning to Medicare Part D Drug Coverage in Seniors Dually Eligible for Medicare and Medicaid
    Shrank, William H.
    Patrick, Amanda R.
    Pedan, Alex
    Polinski, Jennifer M.
    Varasteh, Laleh
    Levin, Raisa
    Liu, Nan
    Schneeweiss, Sebastian
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (12) : 2304 - 2310
  • [47] TRENDS IN SPECIALTY PHARMACY USE AMONG US MEDICARE BENEFICIARIES: IMPLICATIONS FOR PART D POLICY
    Doshi, J. A.
    Li, P.
    Geng, Z.
    Lin, J.
    VALUE IN HEALTH, 2024, 27 (06) : S212 - S212
  • [48] The Medicare Part D drug benefit: Lessons from the experience with drug discount cards
    Doering, PL
    AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY, 2005, 14 (06): : 308 - 312
  • [49] Trends in the prescription drug plans delivering the Medicare Part D Prescription Drug Benefit
    Brill, Joel V.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (15) : S3 - S6
  • [50] Cost Minimization of Medicare Part D Prescription Drug Plan Expenditures
    Patel, Rajul A.
    Lipton, Helene Levens
    Cutler, Timothy W.
    Smith, Amanda R.
    Tsunoda, Shirley M.
    Stebbins, Marilyn R.
    AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (08): : 545 - 553
12345